Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Mabro, M
Artru, P
Gilles, V
Lotz, JP
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
Maindrault-Goebel, F
Louvet, C
Andre, T
Carola, E
Lotz, JP
Molitor, JL
Garcia, ML
Gilles-Amar, V
Izrael, V
Krulik, M
de Gramont, A
Citation: F. Maindrault-goebel et al., Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6), EUR J CANC, 35(9), 1999, pp. 1338-1342
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
Couteau, C
Mabro, M
Lotz, JP
Gilles-Amar, V
Krulik, M
Carola, E
Izrael, V
de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347
Authors:
Andre, T
Bensmaine, MA
Louvet, C
Francois, E
Lucas, V
Desseigne, F
Beerblock, K
Bouche, O
Carola, E
Merrouche, Y
Morvan, F
Dupon-Andre, G
de Gramont, A
Citation: T. Andre et al., Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J CL ONCOL, 17(11), 1999, pp. 3560-3568
Authors:
Mabro, M
Gilles-Amar, V
Louvet, C
Carola, E
Maindrault-Goebel, F
de Gramont, A
Krulik, M
Citation: M. Mabro et al., Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: a report of 50 patients., REV MED IN, 20(10), 1999, pp. 863-868